Sodium Stibogluconate

Sodium Stibogluconate is an antiparasitic medication used to treat leishmaniasis, a disease caused by Leishmania parasites. These parasites are transmitted through the bite of infected female sandflies and can result in a range of symptoms, including skin lesions, swelling, and visceral organ involvement. Sodium Stibogluconate, which is administered intravenously, works by disrupting the growth and reproduction of the Leishmania parasites, ultimately eliminating them from the host. The medication is commonly prescribed to treat cutaneous and mucocutaneous forms of leishmaniasis, and its efficacy in treating visceral leishmaniasis is also well established. It is important for patients to complete the full course of therapy, as incomplete treatment can lead to relapse. Healthcare providers must monitor patients for potential side effects of sodium stibogluconate treatment, such as liver and kidney complications, and adjust the treatment accordingly to ensure patient safety and optimal health outcomes.